Our top pick for
Titan Medical Inc is a medical devices business based in the US. Titan Medical shares (TMDI) are listed on the NASDAQ and all prices are listed in US Dollars.
Since the stock market crash in March caused by coronavirus, Titan Medical's share price has had significant positive movement.
Its last market close was USD$0.71, which is 46.13% up on its pre-crash value of USD$0.3825 and 481.49% up on the lowest point reached during the March crash when the shares fell as low as USD$0.1221.
If you had bought USD$1,000 worth of Titan Medical shares at the start of February 2020, those shares would have been worth USD$417.82 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,460.60.
|Latest market close||USD$0.71|
|52-week range||USD$0.1221 - USD$1.75|
|50-day moving average||USD$0.7425|
|200-day moving average||USD$0.7551|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-2.487|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-20)||N/A|
|1 month (2020-10-30)||1.43%|
|3 months (2020-08-28)||N/A|
|6 months (2020-05-28)||N/A|
|1 year (2019-11-27)||N/A|
|2 years (2018-11-27)||N/A|
|3 years (2017-11-27)||N/A|
|5 years (2015-11-27)||N/A|
Valuing Titan Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Titan Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Titan Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Titan Medical shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||USD$10 million|
|Gross profit TTM||USD$0|
|Return on assets TTM||-4.97%|
|Return on equity TTM||0%|
|Market capitalisation||USD$78.3 million|
TTM: trailing 12 months
There are currently 946,766 Titan Medical shares held short by investors – that's known as Titan Medical's "short interest". This figure is 1.7% down from 962,921 last month.
There are a few different ways that this level of interest in shorting Titan Medical shares can be evaluated.
Titan Medical's "short interest ratio" (SIR) is the quantity of Titan Medical shares currently shorted divided by the average quantity of Titan Medical shares traded daily (recently around 323128.32764505). Titan Medical's SIR currently stands at 2.93. In other words for every 100,000 Titan Medical shares traded daily on the market, roughly 2930 shares are currently held short.
However Titan Medical's short interest can also be evaluated against the total number of Titan Medical shares, or, against the total number of tradable Titan Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Titan Medical's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Titan Medical shares in existence, roughly 10 shares are currently held short) or 0.0116% of the tradable shares (for every 100,000 tradable Titan Medical shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Titan Medical.
Find out more about how you can short Titan Medical stock.
We're not expecting Titan Medical to pay a dividend over the next 12 months.
Titan Medical's shares were split on a 1:30 basis on 19 June 2018. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Titan Medical shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Titan Medical shares which in turn could have impacted Titan Medical's share price.
Over the last 12 months, Titan Medical's shares have ranged in value from as little as $0.1221 up to $1.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Titan Medical's is 4.3202. This would suggest that Titan Medical's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.
Steps to owning and managing CCF, with 24-hour and historical pricing before you buy.
Steps to owning and managing CDW, with 24-hour and historical pricing before you buy.
Steps to owning and managing CWH, with 24-hour and historical pricing before you buy.
Steps to owning and managing CBIO, with 24-hour and historical pricing before you buy.
Steps to owning and managing BLIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing CVGW, with 24-hour and historical pricing before you buy.
Steps to owning and managing AEGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing AJG, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABB, with 24-hour and historical pricing before you buy.
Steps to owning and managing YGYI, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.